Author

N. B. Singanallur

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 1 Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:mouse· 2 Assay:proteomics· 2 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1 Organism:rat· 1 Approach:statistical model· 1

Frequent Co-Authors

A. J. McAuley· 2 shared M. S. Khan· 2 shared R. Singh· 2 shared R. Varadarajan· 2 shared S. Goldie· 2 shared S. K. Malladi· 2 shared S. Pandey· 2 shared S. S. Vasan· 2 shared

Activity by Year

2021-2022 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

A. J. McAuley

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Highly Thermotolerant SARS-CoV-2 Vaccine Elicits Neutralising Antibodies Against Delta and Omicron in Mice

P. Jansen van Vuren, A. J. McAuley, M. J. Kuiper, N. B. Singanallur, M. P. Bruce, S. Riddell, S. Goldie, S. Mangalaganesh, S. Chahal, T. W. Drew, K. R. Blasdell, M. Tachedjian, L. Caly, J. D. Druce, S. Ahmed, , S. S. Vasan

This study evaluates a highly thermotolerant SARS-CoV-2 vaccine in mice, showing it elicits neutralizing antibodies against Delta and Omicron variants.

bioRxiv · Mar 3, 2022Immunology

Immunogenicity and protective efficacy of a highly thermotolerant, trimeric SARS-CoV-2 receptor binding domain derivative

S. K. Malladi, U. R. Patel, R. S. Rajmani, R. Singh, S. Pandey, S. Kumar, S. Khaleeq, P. J. v. Vuren, S. S. Riddell, S. Goldie, S. Gayathri, D. Chakraborty, P. Kalita, I. Pramanick, N. Agarwal, , R. Varadarajan

This study designs a thermotolerant trimeric RBD vaccine candidate that elicits strong neutralizing antibodies against multiple SARS-CoV-2 variants in animal models.

bioRxiv · Jan 13, 2021Microbiology